24
Participants
Start Date
October 15, 2025
Primary Completion Date
December 30, 2025
Study Completion Date
March 30, 2026
Cerogrin
Participants in this arm will receive transcutaneous auricular vagus nerve stimulation using the Cerogrin device. This device non-invasively delivers electrical stimulation to the vagus nerve located on the outer ear, aiming to improve cognitive function.
Sham Device
Participants in this arm will use a sham device. This device is identical in appearance to the active Cerogrin device but delivers no electrical stimulation or therapeutic effect. The sham device serves as a control to compare outcomes with the active treatment group.
Neurogrin Inc.
INDUSTRY